LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

Search

Omnicell Inc

Fechado

SetorSaúde

34.03 -2.77

Visão Geral

Variação de preço das ações

24h

Atual

Mín

33.88

Máximo

35.03

Indicadores-chave

By Trading Economics

Rendimento

-177K

5.5M

Vendas

20M

311M

P/E

Médio do Setor

85.605

105.69

EPS

0.51

Margem de lucro

1.758

Funcionários

3,600

EBITDA

-935K

29M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+18.95% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

249M

1.7B

Abertura anterior

36.8

Fecho anterior

34.03

Sentimento de Notícias

By Acuity

50%

50%

185 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de nov. de 2025, 18:59 UTC

Grandes Movimentos do Mercado

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

17 de nov. de 2025, 23:40 UTC

Conversa de Mercado

Gold Consolidates Amid Mixed Signals -- Market Talk

17 de nov. de 2025, 23:34 UTC

Conversa de Mercado

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

17 de nov. de 2025, 22:58 UTC

Conversa de Mercado

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

17 de nov. de 2025, 22:46 UTC

Conversa de Mercado

Risk Assets Set to Have a Strong 2026 -- Market Talk

17 de nov. de 2025, 22:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

17 de nov. de 2025, 22:02 UTC

Ganhos

Trip.com Group 3Q Rev $2.6B >TCOM

17 de nov. de 2025, 22:02 UTC

Ganhos

Trip.com Group 3Q Adj EPS $3.87 >TCOM

17 de nov. de 2025, 22:02 UTC

Ganhos

Trip.com Group 3Q EPS $4.02 >TCOM

17 de nov. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de nov. de 2025, 21:40 UTC

Ganhos

James Hardie Industries 2Q Adj EPS 26c >JHX

17 de nov. de 2025, 21:40 UTC

Ganhos

James Hardie Industries 2Q Loss/Shr 10c >JHX

17 de nov. de 2025, 21:39 UTC

Ganhos

James Hardie Industries 2Q Sales $1.29B >JHX

17 de nov. de 2025, 21:38 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 de nov. de 2025, 21:38 UTC

Ganhos

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

17 de nov. de 2025, 21:10 UTC

Ganhos

XP Inc. 3Q EPS BRL2.47 >XP

17 de nov. de 2025, 21:10 UTC

Ganhos

XP Inc. 3Q Rev BRL4.67B >XP

17 de nov. de 2025, 20:20 UTC

Conversa de Mercado

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

17 de nov. de 2025, 20:12 UTC

Conversa de Mercado

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

17 de nov. de 2025, 20:12 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de nov. de 2025, 20:09 UTC

Conversa de Mercado

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

17 de nov. de 2025, 19:29 UTC

Conversa de Mercado

Gold Slide Continues to Start Week -- Market Talk

17 de nov. de 2025, 19:16 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 de nov. de 2025, 18:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

17 de nov. de 2025, 16:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

17 de nov. de 2025, 16:16 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 de nov. de 2025, 16:15 UTC

Ganhos

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

17 de nov. de 2025, 15:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

17 de nov. de 2025, 15:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

17 de nov. de 2025, 15:19 UTC

Conversa de Mercado

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

18.95% parte superior

Previsão para 12 meses

Média 40.67 USD  18.95%

Máximo 45 USD

Mínimo 34 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

5 ratings

3

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

185 / 374 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat